首页> 外国专利> SOLID, ORALLY ADMINISTERED, WATER-DISPERSIBLE PHARMACEUTICAL FORM FOR THE TREATMENT OF TUBERCULOSIS, CONTAINING RIFAMPICIN, ISONIAZID, PIRAZINAMIDE AND PYRIDOXINE HYDROCHLORIDE, METHOD FOR OBTAINING AND PRESENTATION FORM OF SAID PHARMACEUTICAL FORM

SOLID, ORALLY ADMINISTERED, WATER-DISPERSIBLE PHARMACEUTICAL FORM FOR THE TREATMENT OF TUBERCULOSIS, CONTAINING RIFAMPICIN, ISONIAZID, PIRAZINAMIDE AND PYRIDOXINE HYDROCHLORIDE, METHOD FOR OBTAINING AND PRESENTATION FORM OF SAID PHARMACEUTICAL FORM

机译:用于治疗结核病的固体,口服减毒,水分散性药物制剂,包含利福平,异烟肼,吡嗪酰胺和吡ID醇盐酸盐,所述药物的呈递形式和表示形式

摘要

The pharmaceutical form contains rifampicin, isoniazid, pirazinamide and pyridoxine hydrochloride as active substances in a water-dispersible solid, granular matrix. Once reconstituted in water, said pharmaceutical gives rise to a pleasant tasting suspension. The method for obtaining said pharmaceutical form involves the following steps: simply mixing the components or separately obtaining rifampicin granules and isoniazid and pirazinamide granules and, optionally, pyridoxine hydrochloride granules; mixing and homogenizing said granules. The pharmaceutical form is suitable for preparing a presentation form of a medicament containing rifampicin, isoniazid, pirazinamide and pyridoxine hydrochloride, for example in the form of single dose envelopes containing said pharmaceutical form in a therapeutically effective dose.
机译:药物形式在水分散性固体颗粒基质中包含利福平,异烟肼,吡嗪酰胺和吡ido醇盐酸盐作为活性物质。一旦在水中重构,所述药物产生令人愉快的品尝悬浮液。获得所述药物形式的方法包括以下步骤:简单地混合组分或分别获得利福平颗粒和异烟肼和吡嗪酰胺颗粒,以及任选地吡ido醇盐酸盐颗粒;混合并均化所述颗粒。该药物形式适合于制备包含利福平,异烟肼,吡嗪酰胺和吡ido醇盐酸盐的药物的呈药形式,例如以包含治疗有效剂量的所述药物形式的单剂量包膜形式。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号